KSPHF (Kissei Pharmaceutical Co) Cyclically Adjusted PB Ratio: (As of Sep. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

KSPHF Kissei Pharmaceutical Co Ltd KSPHF
77 GF Score
Price $25.77
GF Value $30.13
! 1 Warning Sign
View Full Analysis

What is Kissei Pharmaceutical Co Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Kissei Pharmaceutical Co  (OTCPK:KSPHF) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Kissei Pharmaceutical Co Cyclically Adjusted PB Ratio Related Terms


Kissei Pharmaceutical Co Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Kissei Pharmaceutical Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kissei Pharmaceutical Co Cyclically Adjusted PB Ratio Chart

Kissei Pharmaceutical Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.63 0.54 0.64 0.64 0.67

Kissei Pharmaceutical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.72 0.80 0.71 0.68 0.67

KSPHF vs ZTS: Cyclically Adjusted PB Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Kissei Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kissei Pharmaceutical Co Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kissei Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Kissei Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.


KSPHF
77GF Score
Kissei Pharmaceutical Co Ltd KSPHF
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kissei Pharmaceutical Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Kissei Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Kissei Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=34.206/113.6000*113.6000
=34.206

Current CPI (Jun. 2026) = 113.6000.

Kissei Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
201609 31.591 98.000 36.620
201612 28.114 98.400 32.457
201703 29.306 98.100 33.936
201706 29.778 98.500 34.343
201709 30.565 98.800 35.144
201712 32.452 99.400 37.088
201803 35.443 99.200 40.588
201806 34.659 99.200 39.690
201809 35.037 99.900 39.842
201812 33.847 99.700 38.566
201903 35.282 99.700 40.201
201906 35.847 99.800 40.804
201909 37.102 100.100 42.106
201912 38.295 100.500 43.287
202003 38.263 100.300 43.337
202006 42.567 99.900 48.405
202009 44.430 99.900 50.523
202012 44.503 99.300 50.912
202103 43.163 99.900 49.082
202106 42.174 99.500 48.150
202109 40.269 100.100 45.700
202112 37.789 100.100 42.885
202203 36.121 101.100 40.587
202206 32.367 101.800 36.119
202209 30.099 103.100 33.164
202212 32.327 104.100 35.277
202303 31.741 104.400 34.538
202306 29.690 105.200 32.061
202309 29.501 106.200 31.557
202312 31.530 106.800 33.538
202403 33.053 107.200 35.026
202406 31.068 108.200 32.619
202409 34.915 108.900 36.422
202412 31.412 110.700 32.235
202503 32.827 111.100 33.566
202506 34.791 111.700 35.383
202509 34.732 112.000 35.228
202512 33.508 113.000 33.686
202603 35.110 112.700 35.390
202606 34.206 113.600 34.206

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Kissei Pharmaceutical Co (KSPHF) Overvalued in 2026?

Based on GuruFocus' analysis, Kissei Pharmaceutical Co stock appears to be undervalued. The current stock price of $25.77 is trading 14.5% below its estimated GF Value™ of $30.13.

Key valuation signals for KSPHF:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: $30.13 vs. price of $25.77 (14.5% below fair value)
  • GF Score™: 77/100 with 1 warning sign

No single metric tells the full story. See the KSPHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Kissei Pharmaceutical Co Business Description

Other Exchanges 4547:Japan
Address 19-48, Yoshino, Matsumoto City, Nagano, JPN, 399-8710
Kissei Pharmaceutical Co Ltd is a specialty and generic drug manufacturing company. Pharmaceuticals is the company's reportable segment. The company's operations span across the globe, while the vast majority of revenue is generated in Japan, followed by Europe. Kissei operates a variety of subsidiaries. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
77GF Score

Get the complete analysis for KSPHF

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$25.77
Price
$30.13
GF Value